Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9428538 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Inhaled Nitric Oxide for the Adjunctive Therapy of Severe Malaria: a Randomized Controlled Trial
Condition: Severe Malaria
Intervention: Drug: Inhaled Nitric Oxide

Indicates status has not been verified in more than two years